N4 Pharma (N4P)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 0.80p
   
  • Change Today:
      0.000p
  • 52 Week High: 3.07
  • 52 Week Low: 0.75
  • Currency: UK Pounds
  • Shares Issued: 268.78m
  • Volume: 18,358
  • Market Cap: 2.15m
2016-10-17 - Suspension of Listing

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -71250.0% n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 1075.1 n/a
Pr/Book 1.8  
Latest F'cast
Revenue n/a n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

N4 Pharma Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-19 n/a (0.95) (0.87)p n/a n/a n/a n/a 0.0%
31-Dec-20 n/a (1.57) (0.96)p n/a n/a n/a n/a 0.0%
31-Dec-21 n/a (1.84) (0.85)p n/a n/a n/a n/a 0.0%
31-Dec-22 n/a (1.19) (0.55)p n/a n/a n/a n/a 0.0%
31-Dec-23 n/a (1.42) (0.52)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

N4 Pharma Company Announcements

Posting of Annual Report & Notice of AGM 29-Apr-2024 10:59 RNS
Collaboration Agreement with SRI International Inc 25-Apr-2024 07:38 RNS
Final Results 23-Apr-2024 07:00 RNS

Latest N4 Pharma Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

N4 Pharma Market Data

Currency UK Pounds
Share Price 0.80p
Change Today 0.000p
% Change 0.00 %
52 Week High 3.07
52 Week Low 0.75
Volume 18,358
Shares Issued 268.78m
Market Cap 2.15m

N4 Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
33.47% below the market average33.47% below the market average33.47% below the market average33.47% below the market average33.47% below the market average
49.02% below the sector average49.02% below the sector average49.02% below the sector average49.02% below the sector average49.02% below the sector average
Value
33.47% below the market average33.47% below the market average33.47% below the market average33.47% below the market average33.47% below the market average
49.02% below the sector average49.02% below the sector average49.02% below the sector average49.02% below the sector average49.02% below the sector average
Income Not Available
Growth Not Available

N4 Pharma Dividends

No dividends found

Trades for 17-May-2024

Time Volume / Share Price
13:10 1,111 @ 0.75p
13:10 228 @ 0.75p
08:48 17,019 @ 0.77p

N4 Pharma Key Personnel

CEO Nigel Theobald

Top of Page